Abstract
Umbilical cord blood (UCB) is widely considered as a potential alternative to bone marrow for haematopoietic stem cells. Efforts on UCB research have now taken a step further with the establishment of numerous cord blood banks throughout the world. Our aim is to improve the efficiency and end product of our bank because of the high running costs and administrative workload involved as well as finding a correlation between the reasons for rejecting UCB units (such as a low volume collected/ cell count) and obstetric factors. In 16 months we obtained 683 cord blood units by withdrawing residual blood from the placenta. The units were cryopreserved within 24 hours of extraction in a volume of at least 60mL with a nucleated cells total of 800 per 106. Analysis of the blood was also performed to exclude any bacterial contamination. However, 340 (49.75%) of the collected units were discarded. The main reasons were: low volume; low cell counts; patient/ family history; bacterial contamination; freezing problems; unit misidentification and no informed consent. Our study indicates that monitoring the reasons for rejecting UCB units on a regular basis could save the precious resources wasted on such units by identifying suitable units beforehand.
Keywords: Haematopoietic stem cells, Umbilical cord, Cryopreservation, Cord blood bank, Nucleated cell counts
Letters in Drug Design & Discovery
Title: Good Practice in Umbilical Cord Blood Collection in Order to Identify Suitable Units Before Cryopreservation
Volume: 7 Issue: 3
Author(s): C. Pafumi, G. Gangarossa, A. Lupo, C. Randazzo, G. Abate, I. La Rosa, M. A. Palumbo, A. Iemmola, F. Gulino, M. Attard and A. C. Plesca
Affiliation:
Keywords: Haematopoietic stem cells, Umbilical cord, Cryopreservation, Cord blood bank, Nucleated cell counts
Abstract: Umbilical cord blood (UCB) is widely considered as a potential alternative to bone marrow for haematopoietic stem cells. Efforts on UCB research have now taken a step further with the establishment of numerous cord blood banks throughout the world. Our aim is to improve the efficiency and end product of our bank because of the high running costs and administrative workload involved as well as finding a correlation between the reasons for rejecting UCB units (such as a low volume collected/ cell count) and obstetric factors. In 16 months we obtained 683 cord blood units by withdrawing residual blood from the placenta. The units were cryopreserved within 24 hours of extraction in a volume of at least 60mL with a nucleated cells total of 800 per 106. Analysis of the blood was also performed to exclude any bacterial contamination. However, 340 (49.75%) of the collected units were discarded. The main reasons were: low volume; low cell counts; patient/ family history; bacterial contamination; freezing problems; unit misidentification and no informed consent. Our study indicates that monitoring the reasons for rejecting UCB units on a regular basis could save the precious resources wasted on such units by identifying suitable units beforehand.
Export Options
About this article
Cite this article as:
Pafumi C., Gangarossa G., Lupo A., Randazzo C., Abate G., Rosa La I., Palumbo A. M., Iemmola A., Gulino F., Attard M. and Plesca C. A., Good Practice in Umbilical Cord Blood Collection in Order to Identify Suitable Units Before Cryopreservation, Letters in Drug Design & Discovery 2010; 7 (3) . https://dx.doi.org/10.2174/157018010790596623
DOI https://dx.doi.org/10.2174/157018010790596623 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Radiotracers in Oncology
Current Radiopharmaceuticals Regulation of Cell Migration and Invasion by Specific Modules of uPA: Mechanistic Insights and Specific Inhibitors
Current Drug Targets Lumiflavin Enhances the Effects of Ionising Radiation on Ovarian Cancer Stem-Like Cells by Inhibiting Autophagy
Anti-Cancer Agents in Medicinal Chemistry LncRNA HOTAIR as Prognostic Circulating Marker and Potential Therapeutic Target in Patients with Tumor Diseases
Current Drug Targets Aspartic Proteases of Human Pathogenic Fungi are Prospective Targets for the Generation of Novel and Effective Antifungal Inhibitors
Current Enzyme Inhibition Current Research on Opioid Receptor Function
Current Drug Targets The Effects of Sevoflurane or Remifentanil on the Stress Response to Surgical Stimulus
Current Pharmaceutical Design Type Specific Human Papilloma Virus Prevalence and Distribution in Women with Abnormal Cervical Cytology: A Single Centre Retrospective Observational Study in the Emirate of Abu Dhabi
New Emirates Medical Journal The Potential Clinical Impact of Probiotic Treatment for the Prevention and/or Anti-Inflammatory Therapeutic Effect Against Radiation Induced Intestinal Mucositis. A Review
Recent Patents on Inflammation & Allergy Drug Discovery Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?
Current Vascular Pharmacology Discovery of New Inhibitors of Urease Enzyme: A Study Using STD-NMR Spectroscopy
Letters in Drug Design & Discovery The Effects of Exercise on Postpartum Weight Retention in Overweight and Obese Women
Current Women`s Health Reviews Disorders of Sex Development: A Review
Current Women`s Health Reviews Dissecting Insulin Signaling Pathways: Individualised Therapeutic Targets for Diagnosis and Treatment of Insulin Resistant States
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial [Hot Topic: Beyond Gynaecological Cancers: Psychological Challenges (Guest Editor: Vania Goncalves)]
Current Women`s Health Reviews Circulating Advanced Oxidation Protein Products as Oxidative Stress Biomarkers and Progression Mediators in Pathological Conditions Related to Inflammation and Immune Dysregulation
Current Medicinal Chemistry A Novel Method for the Analysis of Soluble Carbohydrates from Cistanche deserticola
Current Analytical Chemistry The Ultrasonographic Diagnosis of Polycystic Ovary Syndrome
Current Medical Imaging Eliminating Ovarian Cancer Stem Cells: A Potential Therapeutic Target for Ovarian Cancer Chemoresistance
Current Protein & Peptide Science Dequalinium-Derived Nanoconstructs: A Promising Vehicle for Mitochondrial Targeting
Current Drug Delivery